As a matter of fact, in vivo experiments have implicated that miR-181a could modulate TGF-β signaling to induce and maintain epithelial–mesenchymal transition and further affect ovarian cancer cell survival [50]. This evidence concerns the gene TGFB1 and ovarian cancer.